Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics source : Www.aquestive.com save search
Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences
Published: 2023-04-26 (Crawled : 12:20) - aquestive.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 1.56%
H: 0.77%
C: -3.85%
therapeutics
Aquestive Therapeutics Receives Conditional FDA Acceptance of Proprietary Name Anaphylm™ for Lead Candidate AQST-109 (Epinephrine Sublingual Film)
Published: 2023-04-20 (Crawled : 12:20) - aquestive.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 1.45%
H: 2.86%
C: -1.43%
aqst-109 fda candidate therapeutics
Aquestive Therapeutics to Report First Quarter 2023 Financial Results and Recent Business Highlights on May 2 and Host Conference Call on May 3 at 8:00 a.m. ET
Published: 2023-04-18 (Crawled : 12:20) - aquestive.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 1.82%
H: 1.43%
C: -7.14%
conference report business therapeutics financial results
Aquestive Therapeutics Expands License and Supply Agreement with Pharmanovia for Libervant™ (diazepam) Buccal Film to Additional Global Markets
Published: 2023-03-29 (Crawled : 13:00) - aquestive.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 2.66%
H: 10.85%
C: 8.7%
license global therapeutics agreement
Aquestive Therapeutics to Participate in Oppenheimer 33rd Annual Healthcare Conference
Published: 2023-03-01 (Crawled : 13:20) - aquestive.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 3.42%
H: 0.09%
C: -4.84%
conference therapeutics
Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies for AQST-109 Epinephrine Sublingual Film at American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
Published: 2023-02-21 (Crawled : 13:20) - aquestive.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 1.65%
H: 1.03%
C: -3.93%
aqst-109 immunology meeting therapeutics epinephrine positive
2023 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI)
Published: 2023-02-20 (Crawled : 19:00) - aquestive.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 1.65%
H: 1.03%
C: -3.93%
immunology meeting
Aquestive Therapeutics Provides Business Update and Outlines Key 2023 Objectives
Published: 2023-01-06 (Crawled : 13:20) - aquestive.com
ASRT | $0.754 70K
|
Health Technology
|
| O: 0.46%
H: 1.14%
C: -0.68%
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: -1.14%
H: 6.02%
C: 2.49%
therapeutics update
Aquestive Therapeutics Announces Completion of FDA End-of-Phase 2 Meeting For AQST-109 (epinephrine sublingual film)
Published: 2022-12-22 (Crawled : 13:20) - aquestive.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: -0.38%
H: 5.5%
C: 0.22%
aqst-109 fda meeting therapeutics phase 2
Aquestive Therapeutics Announces Publication of Crossover Food Effect Study of Diazepam Nasal Spray in Epilepsia
Published: 2022-11-29 (Crawled : 13:20) - aquestive.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 2.13%
H: 3.91%
C: -3.48%
spray therapeutics food publication study
Aquestive Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-01 (Crawled : 21:00) - aquestive.com
OPT | $3.4 1.5K
|
Health Technology
|
| O: 0.81%
H: 0.1%
C: -0.6%
ASRT | $0.754 70K
|
Health Technology
|
| O: -0.37%
H: 1.87%
C: -0.75%
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 5.2%
H: 0.0%
C: -6.67%
therapeutics financial update results
Aquestive Therapeutics Announces Positive Decision in States’ Suboxone Antitrust Lawsuit on All Claims
Published: 2022-10-24 (Crawled : 12:20) - aquestive.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 3.0%
H: 0.33%
C: -3.98%
therapeutics positive
Aquestive Therapeutics to Report Third Quarter 2022 Financial Results and Recent Business Highlights on November 1 and Host Conference Call on November 2 at 8:00 a.m. ET
Published: 2022-10-19 (Crawled : 12:20) - aquestive.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 1.1%
H: 0.58%
C: -7.86%
conference report therapeutics financial results
Aquestive Therapeutics Receives Positive FDA Written Response for AQST-109 Epinephrine Sublingual Film
Published: 2022-10-11 (Crawled : 12:20) - aquestive.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 1.96%
H: 8.65%
C: 3.85%
aqst-109 fda therapeutics response epinephrine positive
Aquestive Therapeutics Enters License and Supply Agreement with Pharmanovia for Libervant™ (diazepam) Buccal Film for European and MENA Markets
Published: 2022-09-28 (Crawled : 12:20) - aquestive.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: -7.02%
H: 11.31%
C: 9.43%
license therapeutics agreement
Aquestive Therapeutics Announces Positive EPIPHAST II Trial Data for AQST-109 When Compared to EpiPen®
Published: 2022-09-27 (Crawled : 12:00) - aquestive.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 12.05%
H: 1.2%
C: -9.16%
aqst-109 epipen trial therapeutics positive
Aquestive Therapeutics Announces Expert Allergy Scientific Advisory Board
Published: 2022-09-12 (Crawled : 21:00) - aquestive.com
MS | News 0 d | $90.92 0.73% 950K
|
Finance
|
| O: -2.37%
H: 0.76%
C: -1.09%
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: -2.08%
H: 2.13%
C: -2.13%
therapeutics
Aquestive Therapeutics to Participate in Two Investor Conferences in September
Published: 2022-08-31 (Crawled : 21:00) - aquestive.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: -5.88%
H: 2.21%
C: -5.15%
therapeutics
Aquestive Therapeutics Receives FDA Tentative Approval for Libervant™ (diazepam) Buccal Film
Published: 2022-08-31 (Crawled : 12:20) - aquestive.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: -6.58%
H: 3.52%
C: 1.76%
fda tentative approval therapeutics
Aquestive Therapeutics to Participate in Wedbush PacGrow Healthcare Conference
Published: 2022-07-26 (Crawled : 12:20) - aquestive.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: -0.35%
H: 3.14%
C: -6.4%
conference therapeutics
Gainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0835 131.94% 160M
|
ZCMD | $2.18 50.35% 24M
|
Commercial Services
CHRO | $1.73 41.22% 46K
|
n/a
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.3174 31.1% 28M
|
Manufacturing
WISA 4 | $7.11 20.71% 4.7M
|
Electronic Technology
LIFW | News | $0.99 19.26% 800K
|
Administrative and Support and ...
PRTG | $0.285 18.75% 140K
|
Mining, Quarrying, and Oil and ...
Your saved searches
Save your searches and get alerts when important news are released.